Gabriela Bukovska

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Urinary Tract Infection

Systematic Review

Candida Albicans

Induced Pluripotent Stem Cells

Top Venues

Applied microbiology and biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Kajsikova, Michal Kajsik, Lucia Bocanova, Kristina Papayova, Hana Drahovská, Gabriela Bukovska
Endolysin EN572-5 as an alternative to treat urinary tract infection caused by Streptococcus agalactiae. Applied microbiology and biotechnology 108 (1) (2024)
Maria Kajsikova, Michal Kajsik, Lucia Bocanova, Kristina Papayova, Hana Drahovská, Gabriela Bukovska
Endolysin EN572-5 as an alternative to treat urinary tract infection caused by Streptococcus agalactiae. Applied microbiology and biotechnology 108 (1) (2024)
Maria Kajsikova, Michal Kajsik, Lucia Bocanova, Kristina Papayova, Hana Drahovská, Gabriela Bukovska
Endolysin EN572-5 as an alternative to treat urinary tract infection caused by Streptococcus agalactiae. Applied microbiology and biotechnology 108 (1) (2024)
Maria Kajsikova, Michal Kajsik, Lucia Bocanova, Kristina Papayova, Hana Drahovská, Gabriela Bukovska
Endolysin EN572-5 as an alternative to treat urinary tract infection caused by Streptococcus agalactiae. Applied microbiology and biotechnology 108 (1) (2024)
Maria Kajsikova, Michal Kajsik, Lucia Bocanova, Kristina Papayova, Hana Drahovská, Gabriela Bukovska
Endolysin EN572-5 as an alternative to treat urinary tract infection caused by Streptococcus agalactiae. Applied microbiology and biotechnology 108 (1) (2024)
Maria Kajsikova, Michal Kajsik, Lucia Bocanova, Kristina Papayova, Hana Drahovská, Gabriela Bukovska
Endolysin EN572-5 as an alternative to treat urinary tract infection caused by Streptococcus agalactiae. Applied microbiology and biotechnology 108 (1) (2024)
Maria Kajsikova, Michal Kajsik, Lucia Bocanova, Kristina Papayova, Hana Drahovská, Gabriela Bukovska
Endolysin EN572-5 as an alternative to treat urinary tract infection caused by Streptococcus agalactiae. Applied microbiology and biotechnology 108 (1) (2024)
Aneta Lichvariková, Katarina Soltys, Tomas Szemes, Livia Slobodnikova, Gabriela Bukovska, Jan Turna, Hana Drahovska
Characterization of Clinical and Carrier Streptococcus agalactiae and Prophage Contribution to the Strain Variability. Viruses 12 (11) (2020)